INOVIO PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
INOVIO PHARMACEUTICALS, INC. (INO) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $201.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $201.00K.
- INOVIO PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $841.00K, a 44.50% increase from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $582.00K.
- INOVIO PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $3.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $201.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $841.00K 10-K · filed 2025-03-18 |
| 2022-12-31 | $582.00K 10-K · filed 2024-03-06 |
| 2019-12-31 | $3.00K 10-K · filed 2022-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2017-12-31 | $74.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |